Platelet Aggregation Devices Market Size, Growth, Scope and Forecast 2026
According to the latest report by IMARC Group, titled " Platelet Aggregation Devices Market : Global Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026 ; the global platelet aggregation devices market exhibited moderate growth during 2015-2020.Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Platelet aggregation devices consist of adenosine-diphosphate (ADP), thrombin, and ristocetin-induced platelet aggregation (RIPA). These devices are utilized to diagnose patients with inherited and acquired platelet function disorders, including excessive bleeding, arterial thrombotic, stroke, myocardial infarction, etc. Platelet aggregation devices aid in transfusing medicines, pre-surgery tests, and clinical settings to monitor the response of antiplatelet therapies and assess perioperative bleeding risk. Presently, due to the launch of new potential biomarkers and technologies, platelet aggregation devices are finding extensive...